Related Experiment Videos

Limiting and rationing treatment in paediatric and neonatal intensive care

Peter-Marc Fortune1

  • 1Royal Manchester Children's Hospital, Pendlebury, Manchester M20 3FJ, UK. peter-marc.fortune@manchester.ac.uk

Best Practice & Research. Clinical Anaesthesiology
|January 16, 2007
PubMed

Insights

This chapter explores ethical decisions for pediatric intensive care, focusing on end-of-life care, futility, and resource allocation. It offers practical guidance for clinicians on life-limiting discussions and treatment withdrawal.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Medical Ethics
  • Bioethics

Background:

  • Ethical dilemmas are common in pediatric intensive care.
  • End-of-life decision-making requires careful consideration of complex factors.
  • Resource allocation for critical care services presents unique challenges.

Purpose of the Study:

  • To examine ethical decisions regarding treatment provision and limitation in pediatric intensive care.
  • To explore the impact of futility, burden, and uncertainty on end-of-life decisions.
  • To discuss resource allocation for children's critical care.

Main Methods:

  • A practical, clinically-oriented approach to ethical issues.
  • Analysis of key considerations in life-limiting discussions: why, when, who, how, and where.
  • Focus on clinical practice rather than purely philosophical principles.

Main Results:

  • Provides a framework for engaging in life-limiting discussions.
  • Highlights the importance of considering futility, burden, and uncertainty.
  • Offers practical insights for clinicians managing complex pediatric critical care cases.

Conclusions:

  • Ethical decision-making in pediatric intensive care requires a practical, patient-centered approach.
  • Effective communication and clear guidelines are essential for end-of-life care.
  • Balancing treatment limitations with resource allocation is crucial for optimal care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...